Hambleton Julie

Five Prime Therapeutics, Inc.

EVP & Chief Medical Officer

Avg. Two Year Performance

265% Avg. Purchase Return 91% Compound

17% Avg. Sale Return 8% Compound

Holdings: 86.58K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions